Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The association between interferon lambda 3 and 4 gene single-nucleotide polymorphisms and the recovery of COVID-19 patients
Pooneh Rahimi, Rahil Tarharoudi, Alireza Rahimpour, et al.
Virology Journal (2021) Vol. 18, Iss. 1
Open Access | Times Cited: 54

Showing 1-25 of 54 citing articles:

Systematic review and meta-analysis of human genetic variants contributing to COVID-19 susceptibility and severity
Kajal Gupta, Gaganpreet Kaur, Tejal Pathak, et al.
Gene (2022) Vol. 844, pp. 146790-146790
Open Access | Times Cited: 54
The association of COVID-19 severity and susceptibility and genetic risk factors: A systematic review of the literature
Angela Ishak, Meghana Mehendale, Mousa M. AlRawashdeh, et al.
Gene (2022) Vol. 836, pp. 146674-146674
Open Access | Times Cited: 38
Genetic susceptibility to severe COVID-19
Claudio Cappadona, Valeria Rimoldi, Elvezia Maria Paraboschi, et al.
Infection Genetics and Evolution (2023) Vol. 110, pp. 105426-105426
Open Access | Times Cited: 26
Association between interleukin-10 gene polymorphisms (rs1800871, rs1800872, and rs1800896) and severity of infection in different SARS-CoV-2 variants
Sattar Jabbar Abbood Abbood, Enayat Anvari, Abolfazl Fateh
Human Genomics (2023) Vol. 17, Iss. 1
Open Access | Times Cited: 23
Polymorphisms in ACE1, TMPRSS2, IFIH1, IFNAR2, and TYK2 Genes Are Associated with Worse Clinical Outcomes in COVID-19
Cristine Dieter, Letícia de Almeida Brondani, Natália Emerim Lemos, et al.
Genes (2022) Vol. 14, Iss. 1, pp. 29-29
Open Access | Times Cited: 34
Interferon-λ treatment accelerates SARS-CoV-2 clearance despite age-related delays in the induction of T cell immunity
Deanna M. Santer, Daniel Li, Yanal Ghosheh, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 30
The impact of ACE2 polymorphisms (rs1978124, rs2285666, and rs2074192) and ACE1 rs1799752 in the mortality rate of COVID-19 in different SARS-CoV-2 variants
Farzaneh Sheikhian, Sahar Sadeghi Mofrad, Samira Tarashi, et al.
Human Genomics (2023) Vol. 17, Iss. 1
Open Access | Times Cited: 16
The association of cytokine gene polymorphisms with the development and course of COVID-19
N. I. Baranova, L.A. Ashchina, Oksana Alexandrovna Kulieva, et al.
Journal Infectology (2025) Vol. 17, Iss. 1, pp. 36-45
Open Access
The death rate of COVID-19 infection in different SARS-CoV-2 variants was related to C-reactive protein gene polymorphisms
Sahar Sadeghi Mofrad, Shayan Boozarjomehri Amnieh, Mohammad Reza Pakzad, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4
Modeling the emergence of viral resistance for SARS-CoV-2 during treatment with an anti-spike monoclonal antibody
Tin Phan, Carolin Zitzmann, Kara W. Chew, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 4, pp. e1011680-e1011680
Open Access | Times Cited: 4
Impact of interferon-induced transmembrane protein 3 gene rs12252 polymorphism on COVID-19 mortality
Iraj Ahmadi, Alireza Afifipour, Fatemeh Sakhaee, et al.
Cytokine (2022) Vol. 157, pp. 155957-155957
Open Access | Times Cited: 19
IFNL1 rs30461 polymorphism as a risk factor for COVID-19 severity: A cross-sectional study
Maha O. Hammad, Mahmoud M. Alseoudy, Asmaa M. Borg, et al.
Cytokine (2024) Vol. 176, pp. 156500-156500
Closed Access | Times Cited: 3
FURIN, IFNL4, and TLR2 gene polymorphisms in relation to COVID-19 severity: a case–control study in Egyptian patients
Gamalat A. Elgedawy, Naglaa Elabd, Radwa Salem, et al.
Infection (2024)
Open Access | Times Cited: 3
Increased risk of COVID-19 mortality rate in IFITM3 rs6598045 G allele carriers infected by SARS-CoV-2 delta variant
Melika Gholami, Fatemeh Sakhaee, Fattah Sotoodehnejadnematalahi, et al.
Human Genomics (2022) Vol. 16, Iss. 1
Open Access | Times Cited: 17
Biomarkers of immunothrombosis and polymorphisms of IL2, IL6, and IL10 genes as predictors of the severity of COVID-19 in a Kazakh population
Assiya Yessenbayeva, Bakytbek Apsalikov, Meruyert Massabayeva, et al.
PLoS ONE (2023) Vol. 18, Iss. 6, pp. e0288139-e0288139
Open Access | Times Cited: 9
Molecular Understanding of ACE-2 and HLA-Conferred Differential Susceptibility to COVID-19: Host-Directed Insights Opening New Windows in COVID-19 Therapeutics
Ihtisham Ul Haq, Katarzyna Krukiewicz, Hamnah Tayyab, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 7, pp. 2645-2645
Open Access | Times Cited: 8
Interferon-Induced Transmembrane Protein 3 rs34481144 C/T Genotype and Clinical Parameters Related to Progression of COVID-19
Melika Gholami, Fatemeh Sakhaee, Fahimeh Mirzaei Gheinari, et al.
Journal of Immunology Research (2023) Vol. 2023, pp. 1-8
Open Access | Times Cited: 8
Evaluating the Role of BglI rs739837 and TaqI rs731236 Polymorphisms in Vitamin D Receptor with SARS-CoV-2 Variants Mortality Rate
Wisam Hasan Madhloom Albu-Mohammed, Enayat Anvari, Abolfazl Fateh
Genes (2022) Vol. 13, Iss. 12, pp. 2346-2346
Open Access | Times Cited: 13
Role of FokI rs2228570 and Tru9I rs757343 Polymorphisms in the Mortality of Patients Infected with Different Variants of SARS-CoV-2
Hasan Rahman Shawi Shawi, Enayat Anvari, Abolfazl Fateh
Archives of Medical Research (2023) Vol. 54, Iss. 4, pp. 310-318
Open Access | Times Cited: 7
Spotlight on contributory role of host immunogenetic profiling in SARS-CoV-2 infection: Susceptibility, severity, mortality, and vaccine effectiveness
Somayeh Yazdanparast, Mehdi Bakhtiyaridovvombaygi, Fatemeh Mikanik, et al.
Life Sciences (2023) Vol. 328, pp. 121907-121907
Open Access | Times Cited: 7
On the relationship between tripartite motif-containing 22 single-nucleotide polymorphisms and COVID-19 infection severity
Nidhal Raheem Juhi Al-Kaabi, Sepideh Chodari Khameneh, Mohadeseh Montazeri, et al.
Human Genomics (2022) Vol. 16, Iss. 1
Open Access | Times Cited: 11
IFNL3/4 polymorphisms as a two‐edged sword: An association with COVID‐19 outcome
Sanja Matić, Dragan Milovanović, Željko Mijailović, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 2
Open Access | Times Cited: 6
Its all about IFN‐λ4: Protective role of IFNL4 polymorphism against COVID‐19‐related pneumonia in females
Sanja Matić, Dragan Milovanović, Željko Mijailović, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 10
Open Access | Times Cited: 6
Association of Interferon Lambda 3 and 4 Gene SNPs and Their Expression with COVID-19 Disease Severity: A Cross-Sectional Study
Warisha Zahid, Nida Farooqui, Nida Zahid, et al.
Infection and Drug Resistance (2023) Vol. Volume 16, pp. 6619-6628
Open Access | Times Cited: 6
Severe COVID‐19 represents an undiagnosed primary immunodeficiency in a high proportion of infected individuals
Paul Gray, Adam Bartlett, Stuart G. Tangye
Clinical & Translational Immunology (2022) Vol. 11, Iss. 4
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top